Education
About Us
Working with TipRanks
Follow Us
Clinuvel Pharmaceuticals Limited (CLVLF)
:CLVLF
RESEARCH TOOLSreports
Earnings Data
Report Date
Sep 02, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
0.24Last Year’s EPS
0.31Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 27, 2025
|% Change Since: 10.22%
|Next Earnings Date:Sep 02, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with significant revenue growth and operational successes, such as expansion in treatment networks and ongoing development in the vitiligo program. However, rising expenses and challenges in drug development and regulatory approvals present some concerns. Despite these challenges, the company remains optimistic about future growth and market recognition.Company Guidance
In the recent investor call, CLINUVEL presented impressive financial metrics for the half-year ending December 31, 2024. Their sales increased by 10.5% to $36 million, while total revenues rose by 21% to $43 million. The company managed to keep expenses growth to a modest 2%, leading to a 48% increase in profit before tax, reaching nearly $22 million. Profit after tax grew by almost 30% to $14 million, and earnings per share increased by 27% from $0.22 to $0.28. The balance sheet showed a 7% rise in net assets, with cash reserves climbing by 8% to $198 million. This strong financial performance was accompanied by strategic operational highlights, including expansion in the U.S. and Europe and advancements in their vitiligo program, reflecting CLINUVEL's ongoing commitment to sustainable growth and shareholder value.Strong Financial Performance
Sales grew by 10.5% to $36 million, total revenues increased by 21% to $43 million, and profit before tax rose by 48% to just under $22 million. Profit after tax increased by almost 30% to $14 million.
Earnings Per Share and Cash Reserves
Earnings per share rose by 27% from $0.22 to $0.28, and cash reserves increased by 8% to $198 million.
Operational Success
The company remains debt-free for the 20th consecutive year with an increase of 7% in net assets. The company's model has allowed expansion without needing dilutive capital raises or external debt funding.
Expansion in Treatment Network
Increase in revenues due to more patients being treated and a more frequent dosing of patients across the U.S. and Europe. Successful engagement with physicians who are building a network of treatment centers.
Ongoing Development in Vitiligo Program
Visible repigmentation in trials with plans to expand clinical and nonclinical development. New sites and patients being incorporated into the program.
---
Clinuvel Pharmaceuticals Limited (CLVLF) Earnings, Revenues Date & History
CLVLF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CLVLF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 27, 2025 | $6.95 | $6.95 | 0.00% |
| Aug 29, 2024 | $9.40 | $10.43 | +10.96% |
| Feb 21, 2024 | $10.55 | $9.85 | -6.64% |
| Aug 29, 2023 | $13.55 | $12.68 | -6.42% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Clinuvel Pharmaceuticals Limited (CLVLF) report earnings?
Clinuvel Pharmaceuticals Limited (CLVLF) is schdueled to report earning on Sep 02, 2025, TBA Not Confirmed.
What is Clinuvel Pharmaceuticals Limited (CLVLF) earnings time?
Clinuvel Pharmaceuticals Limited (CLVLF) earnings time is at Sep 02, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CLVLF EPS forecast?
CLVLF EPS forecast for the fiscal quarter 2025 (Q4) is 0.24.
---